双眼iPad游戏与部分时间遮盖治疗5至12岁弱视儿童的随机临床试验
这项多中心非劣效性随机临床试验纳入385名5至13岁弱视儿童,比较每天1小时双眼iPad游戏与每天2小时遮盖优势眼16周的效果。16周时遮盖组弱视眼视力平均提高1.35行,游戏组提高1.05行,校正组间差异0.31行 favoring 遮盖,单侧95%CI上限0.53行超过预设非劣效界值0.5行,非劣效性分析结果不确定。
要点
- 16周时遮盖组弱视眼视力提高1.35行,游戏组提高1.05行,校正差异0.31行 favoring 遮盖。
- 单侧95%CI上限0.53行超过预设非劣效界值0.5行,非劣效性分析结果不确定。
- 仅22.2%有记录文件的游戏组参与者完成超过75%的处方治疗,中位依从性46%。
核心结论
- 在5至13岁弱视儿童中,双眼游戏与遮盖均改善弱视眼视力,尤其在无既往弱视治疗史的5至7岁儿童中更明显。
- 尽管主要非劣效性分析结果不确定,事后分析提示该特定双眼iPad治疗带来的视力改善不如每天处方2小时遮盖。
研究设计与样本
- 多中心、非劣效性随机临床试验,于2014年9月16日至2015年8月28日在社区和机构诊所开展。
- 纳入385名5岁至不足13岁、弱视眼视力20/40至20/200(平均20/63)的斜视性、屈光参差性或两者兼有的弱视儿童。
- 随机分配至16周双眼iPad游戏组(每天处方1小时,190名参与者)或遮盖组(每天遮盖优势眼2小时,195名参与者),随访安排在4、8、12和16周。
- 对完成16周试验的参与者进行改良意向性治疗分析。
主要发现
- 385名参与者中187名为女性(48.6%),平均(SD)年龄8.5(1.9)岁。
- 16周时双眼游戏组弱视眼视力平均提高1.05行(双侧95%CI 0.85-1.24行),遮盖组提高1.35行(双侧95%CI 1.17-1.54行),校正组间差异0.31行 favoring 遮盖(单侧95%CI上限0.53行)。
- 单侧95%CI上限0.53行超过预设非劣效界值0.5行。
- 176名随机分配至双眼游戏且有记录文件数据的参与者中仅39名(22.2%)完成超过75%的处方治疗(中位数46%,四分位距20%-72%)。
- 在无既往弱视治疗史的5至不足7岁参与者中,双眼游戏组弱视眼视力平均(SD)提高2.5(1.5)行,遮盖组提高2.8(0.8)行。
关键数值与推荐
- 非劣效界值为0.5行。
- 双眼游戏组每天处方1小时,遮盖组每天处方遮盖优势眼2小时,疗程16周。
- 主要结局为弱视眼视力从基线至16周的变化。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 主要非劣效性分析结果不确定。
- 事后分析提示该特定双眼iPad治疗带来的视力改善不如每天处方2小时遮盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: A binocular approach to treating anisometropic and strabismic amblyopia has recently been advocated. Initial studies have yielded promising results, suggesting that a larger randomized clinical trial is warranted. OBJECTIVE: To compare visual acuity (VA) improvement in children with amblyopia treated with a binocular iPad game vs part-time patching. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, noninferiority randomized clinical trial was conducted in community and institutional practices from September 16, 2014, to August 28, 2015. Participants included 385 children aged 5 years to younger than 13 years with amblyopia (20/40 to 20/200, mean 20/63) resulting from strabismus, anisometropia, or both. Participants were randomly assigned to either 16 weeks of a binocular iPad game prescribed for 1 hour a day (190 participants; binocular group) or patching of the fellow eye prescribed for 2 hours a day (195 participants; patching group). Study follow-up visits were scheduled at 4, 8, 12, and 16 weeks. A modified intent-to-treat analysis was performed on participants who completed the 16-week trial. INTERVENTIONS: Binocular iPad game or patching of the fellow eye. MAIN OUTCOMES AND MEASURES: Change in amblyopic-eye VA from baseline to 16 weeks. RESULTS: Of the 385 participants, 187 were female (48.6%); mean (SD) age was 8.5 (1.9) years. At 16 weeks, mean amblyopic-eye VA improved 1.05 lines (2-sided 95% CI, 0.85-1.24 lines) in the binocular group and 1.35 lines (2-sided 95% CI, 1.17-1.54 lines) in the patching group, with an adjusted treatment group difference of 0.31 lines favoring patching (upper limit of the 1-sided 95% CI, 0.53 lines). This upper limit exceeded the prespecified noninferiority limit of 0.5 lines. Only 39 of the 176 participants (22.2%) randomized to the binocular game and with log file data available performed more than 75% of the prescribed treatment (median, 46%; interquartile range, 20%-72%). In younger participants (aged 5 to <7 years) without prior amblyopia treatment, amblyopic-eye VA improved by a mean (SD) of 2.5 (1.5) lines in the binocular group and 2.8 (0.8) lines in the patching group. Adverse effects (including diplopia) were uncommon and of similar frequency between groups. CONCLUSIONS AND RELEVANCE: In children aged 5 to younger than 13 years, amblyopic-eye VA improved with binocular game play and with patching, particularly in younger children (age 5 to <7 years) without prior amblyopia treatment. Although the primary noninferiority analysis was indeterminate, a post hoc analysis suggested that VA improvement with this particular binocular iPad treatment was not as good as with 2 hours of prescribed daily patching. TRIAL REGISTRATION: http://www.clinicaltrials.gov Identifier: NCT02200211.
引用
- Holmes JM, Manh VM, Lazar EL, et al. Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. JAMA Ophthalmol. 2016. PMID: 27812703. doi:10.1001/jamaophthalmol.2016.4262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。